Managing the infectious complications associated with pentostatin (Nipent), used alone or in combination with other agents in patients with low-grade lymphomas, poses a significant problem for clinicians. Since there is limited
Nam Dang, MD, PhD
Advertisement
Articles by Nam Dang, MD, PhD
Advertisement
Latest Updated Articles
- Infectious Complications of Pentostatin Therapy
June 1st 2000
Advertisement
Advertisement
Trending on CancerNetwork
1
TERN-701 Earns FDA Breakthrough Therapy Designation in Ph+ CML
2
Duvelisib Shows Significant Activity in R/R Peripheral T-Cell Lymphoma
3
ASCO Releases New Patient-Clinician Communication Guidelines
4
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
5